The so-called AMP-AD knowledge portal provides access to RNA-sequencing, genotype, and clinical data from multiple Alzheimer's disease projects.
DSysMap combines mutation information with protein interaction data to provide a clearer picture of functional changes associated with the development of complex diseases.
At AGBT last week, MinIon users reported de novo genome assembly, human cDNA sequencing, microbial surveillance, and other projects.
The BeHEARD competition will award more than $600,000 worth of technology products and services for rare disease research projects.
The partners plan to develop a commercial platform for running sequence searches based on optical processing technology developed by Optalysys
In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.
Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.
Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.
Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.